Bromocriptine use is associated with decreased smoking rates.

Bromocriptine use is associated with decreased smoking rates.

Dopaminergic transmission in the central nervous system is thought to underlie addictive behaviours, including smoking. One effective smoking cessation drug, bupropion, enhances dopaminergic transmission; conversely, antipsychotic drugs, which are dopamine antagonists, are associated with increased...

Detaylı Bibliyografya
Asıl Yazarlar:	Murphy, M, Hey, K, Johnstone, E, Munafo, M, Walton, R, Willis, B, Harrison, P
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2002

Benzer Materyaller

Association of the mu-opioid receptor gene with smoking cessation.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The genetic basis for smoking behavior: a systematic review and meta-analysis.
Yazar:: Munafò, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Yazar:: Johnstone, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Association of COMT Val108/158Met genotype with smoking cessation.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Central Hyperthermia Treated with Bromocriptine
Yazar:: P. Natteru, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Does cigarette smoking increase time to conception?
Yazar:: Munafo, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt.
Yazar:: Johnstone, E, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Is giving up smoking on the nicotine patch related to genotype?
Yazar:: Yudkin, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Smoking cessation, weight gain, and DRD4 -521 genotype
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Cabergoline or bromocriptine for prolactinoma?
Yazar:: Nicolás Triantafilo, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
Yazar:: Munafo, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
Yazar:: David, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Lack of association of OPRM1 genotype and smoking cessation.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Genes and cigarette smoking.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation.
Yazar:: David, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Bromocriptine in the Management of Central Hyperthermia
Yazar:: Krishnaprasad Narayanankutty, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Repurposing of Bromocriptine for Cancer Therapy
Yazar:: Ean-Jeong Seo, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
Yazar:: Yudkin, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
Yazar:: Rebecca Simon, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Bromocriptine and insulin sensitivity in lean and obese subjects
Yazar:: L Bahler, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
Yazar:: Grossman, A, ve diğerleri
Baskı/Yayın Bilgisi: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
Yazar:: Grossman, A, ve diğerleri
Baskı/Yayın Bilgisi: (1986)

Bromocriptine for type 2 diabetes mellitus
Yazar:: Ooi, Cheow Peng, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Bromocriptine in type 2 diabetes mellitus
Yazar:: C Shivaprasad, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
Yazar:: Spruell, T, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
Yazar:: David, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch.
Yazar:: Yudkin, P, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

CHRNA3 rs1051730 genotype and short-term smoking cessation.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A peripartum cardiomyopathy case treated with bromocriptine
Yazar:: Dilek Yeşilbursa, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
Yazar:: Ismail, I.S., ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2
Yazar:: O A Gerasimenko, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Maternal smoking during late pregnancy and offspring smoking behaviour.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
Yazar:: Uhl, G, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: Abstinence and withdrawal symptoms
Yazar:: Munafo, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
Yazar:: Yiqun Tang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
Yazar:: Grossman, A, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.
Yazar:: Aveyard, P, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.
Yazar:: David, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)